Display Settings:

Format

Send to:

Choose Destination
    Bioorg Med Chem Lett. 2009 Apr 15;19(8):2154-7. Epub 2009 Mar 4.

    Ganoderic acid DM: anti-androgenic osteoclastogenesis inhibitor.

    Source

    Department of Forest and Forest Products Science, Faculty of Agriculture, Kyushu University, Fukuoka, Japan.

    Abstract

    Prostate cancer is the most common cancer in men in Western countries, with a high incidence of bone metastasis. Ganoderic acid DM, with 5alpha-reductase inhibitory and androgen receptor (AR) binding activity, isolated from the ethanol extracts of Ganoderma lucidum, can inhibit prostate cancer cell growth and block osteoclastogenesis.

    PMID:
    19289282
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk